Skip to content
Trial Eligibility
Menu

Lupus Clinical Trials near Miami, FL

21 studies for Lupus are recruiting at 50 sites within 50 miles of Miami, Florida, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lupus trials in the US or all trials near Miami.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lupus studies enrolling near Miami

Showing 21 studies, nearest first.
  1. A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

    NCT06617325

    • Phase 3
    • Ages 16 years and older
    • Sex: All

    Nearest sites: Sl0044 50681 (Miami, FL); Sl0044 50735 (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  2. A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

    NCT07201129

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Allied Biomedical Research Institute (Miami, FL); DH NationalResearchCenters INC (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  3. A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

    NCT07438496

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: LeJenue Research Associates PLLC (Miami, FL); Avanti Clinical Research Corp (Hialeah, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  4. A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

    NCT07332481

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Advance Medical Research Center (Miami, FL); Diverse Clinical Research LLC (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  5. A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

    NCT07355218

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: GTL Medical And Research Group (Miami, FL); Bolanos Clinical Research (Pembroke Pines, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  6. A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

    NCT07570862

    • Phase 2
    • Ages 12 to 70 years
    • Sex: All

    Nearest sites: Miami Dermatology and Laser Research (Miami, FL); Nicklaus Children's Hospital (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  7. A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

    NCT07607964

    • Phase 1
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Allied Biomedical Research Institute /ID# 284408 (Miami, FL); Discovery Health Research Center /ID# 279691 (Plantation, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. VIBRANT: VIB4920 for Active Lupus Nephritis

    NCT05201469

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami Miller School of Medicine: Nephrology & Hypertension Division (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Lupus Landmark Study: A Prospective Registry and Biorepository

    NCT05934149

    • Observational
    • Ages 18 to 110 years
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

    NCT06308978

    • Phase 1
    • Ages 12 to 70 years
    • Sex: All

    Nearest site: Nicklaus Children's Hospital (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

    NCT07260877

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Investigative Site (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

    NCT07430306

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Research Site (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

    NCT06570798

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Bioresearch Partner Coral Terrace (South Miami, FL)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

    NCT07409181

    • Phase 2
    • Ages 18 to 74 years
    • Sex: All

    Nearest site: AARDS Research, Inc. (Aventura, FL)

    Distance to nearest recruiting site
    ~13 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

    NCT07175285

    • Observational
    • Ages 16 years and older
    • Sex: All

    Nearest sites: South Florida Rheumatology (Hollywood, FL); Centre for Rheumatology, Immunology and Arthritis (Fort Lauderdale, FL)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  16. A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

    NCT06419205

    • Phase 2
    • Ages 16 years and older
    • Sex: All

    Nearest site: Investigator Site #3 (Hollywood, FL)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

    NCT06133972

    • Phase 3
    • Ages 12 to 100 years
    • Sex: All

    Nearest sites: GNP Research (Cooper City, FL); IRIS Research and Development (Plantation, FL)

    Distance to nearest recruiting site
    ~20 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  18. A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

    NCT06557265

    • Phase 1/2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Nkarta Investigational Site (Plantation, FL)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

    NCT06581562

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: IRIS Research and Development, LLC (Plantation, FL)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

    NCT06977724

    • Phase 1
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Life Clinical Trials - Colonial Drive - Margate /ID# 276050 (Margate, FL)

    Distance to nearest recruiting site
    ~33 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

    NCT07611214

    • Phase 4
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Life Clinical Trials (Margate, FL)

    Distance to nearest recruiting site
    ~33 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lupus clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.